CSIMarket
 
Beta Bionics Inc   (NASDAQ: BBNX)
 

Beta Bionics Inc's Customers Performance

BBNX



 
BBNX's Source of Revenues During the corresponding time, Beta Bionics Inc recorded a revenue increase by 42.26 % year on year, sequentially revenue grew by 16.68 %. While revenue at the Beta Bionics Inc 's corporate clients

List of BBNX Customers




for the same period Beta Bionics Inc recorded revenue increase by 42.26 % year on year, sequentially revenue grew by 16.68 %.

List of BBNX Customers

Beta Bionics Inc's Business Units
I Let    2.14 % of total Revenue
Single Use Products    67.53 % of total Revenue






Beta Bionics Inc's Comment on Sales, Marketing and Customers



The company focuses on the treatment of Type 1 Diabetes (T1D) through its commercialized device, the iLet, an automated insulin dosing system approved by the FDA for use in adults and children aged six years and older. Its business relies on the successful commercialization of the iLet and may explore additional indications or develop a bihormonal system incorporating both insulin and glucagon for T1D treatment. The company is exposed to risks related to trade regulations, tariffs, sanctions, and international political tensions, which could impact its ability to compete globally and attract customers and suppliers outside the United States.





Beta Bionics Inc’s Comment on Sales, Marketing and Customers


The company focuses on the treatment of Type 1 Diabetes (T1D) through its commercialized device, the iLet, an automated insulin dosing system approved by the FDA for use in adults and children aged six years and older. Its business relies on the successful commercialization of the iLet and may explore additional indications or develop a bihormonal system incorporating both insulin and glucagon for T1D treatment. The company is exposed to risks related to trade regulations, tariffs, sanctions, and international political tensions, which could impact its ability to compete globally and attract customers and suppliers outside the United States.








BBNX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Beta Bionics Inc 865.07 110.00 -66.44 420
SUBTOTAL 0.00 0.00 0.00 -

Sources: Beta Bionics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Beta Bionics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Beta Bionics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.